Market News & Trends
Prokarium Acquires Key Oral Vaccine Technology
Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc. The technology includes Emergent's live Salmonella-based typhoid vaccine Typhella and its…
Sophion & Creacell Announced Successful Demonstration
Sophion and CreaCell recently announced the two companies successfully demonstrated the performances of HEK-hKir2.1 cells on QPatch HT. Inward rectifier potassium channels of the Kir2…
7/18/2012
Prokarium Acquires Key Oral Vaccine Technology Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc. The technology includes Emergent's live…
EMD Millipore Expands Chemical & Reagents Portfolio
EMD Millipore, the Life Science division of Merck KGaA of Germany, recently announced a significant expansion of their chemicals and reagents product line with the introduction…
FDA Approves Cornerstone Therapeutics' ANDA
Cornerstone Therapeutics Inc. recently announced FDA approval of its ANDA for a generic Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release suspension. CRTX 067 was developed through…
ImmunoGen Initiates Trial for Ovarian Cancer & Other Solid Tumors
ImmunoGen, Inc. recently announced the start of clinical testing with its IMGN853 product candidate.The Phase I trial initiated evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and…
7/11/2012
RoundTable Healthcare Acquires DPT Laboratories RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, recently announced that its portfolio company,…
BASF Sells Marine Biopolymers Business
BASF SE and the Norwegian company Seagarden ASA recently announced they have signed a contract to transfer the Chitosan marine biopolymers business. Chitosan marine biopolymers…
Encap Announces Significant Capital Expenditure Program
Encap Drug Delivery recently announced a $2-million capital expenditure program to support its growing CMO activities. Following the earlier expansion in 2008 when the company…
GlobeImmune Files for $69-Million IPO
GlobeImmune, Inc. recently announced it has publicly filed a registration statement with the US SEC relating to a proposed initial public offering of shares of…
Quotient Clinical & Capsugel Announce Collaboration
Quotient Clinical and Capsugel recently announced a collaboration to enable the rapid development and clinical assessment of lipid-based formulations. Together, the companies will use their…
RoundTable Healthcare Acquires DPT Laboratories
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, recently announced that its portfolio company, Renaissance Acquisition Holdings, LLC has…
Starpharma Reports Rapid Advancement of Delivery Program
Starpharma Holdings Ltd recently provided an update on the developments within its substantial drug delivery program. Starpharma's program to enhance the blockbuster cancer drug docetaxel…
MicroDose Therapeutx & Moerae Matrix Announce Collaboration
MicroDose Therapeutx, Inc. and Moerae Matrix, Inc. recently announced they have signed a collaboration agreement to develop a dry powder inhalation product of Moerae's novel…
6/27/2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted to $180 million, the sixth…
Ambrx & Merck to Design & Develop Biologic Drug Conjugates
Ambrx recently announced the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific…
AmDerma & Oculus Enter Multi-Country Agreement
AmDerma Pharmaceuticals, LLC, a privately owned company (and parent company of Quinnova Pharmaceuticals, Inc.) and Oculus Innovative Sciences recently announced the execution of an agreement…
Catalent & Bend Research Form Strategic Partnership
Catalent Pharma Solutions, Inc. and Bend Research Inc. recently announced they have entered into an agreement to provide integrated solutions for pharmaceutical companies seeking to…
Hovione Reports Significant Sales Growth
Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted to $180 million, the sixth consecutive year of sales growth,…
Idenix Announces Positive Clinical Data
Idenix Pharmaceuticals, Inc. recently announced results from an ongoing Phase IIb study of IDX184 in combination with pegylated interferon and ribavirin (PegIFN/RBV). Of the first…
